Market Closed -
Hong Kong S.E.
01:38:22 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.243
HKD
|
-0.82%
|
|
+14.08%
|
-42.82%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
649
|
237
|
234.3
|
210.6
|
62.42
|
96.34
|
Enterprise Value (EV)
1 |
642.2
|
244.3
|
220.2
|
223.7
|
80.58
|
121.1
|
P/E ratio
|
-5
x
|
-1.3
x
|
-2.99
x
|
-7.56
x
|
-1.45
x
|
-4.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.24
x
|
2.65
x
|
4.28
x
|
0.76
x
|
0.41
x
|
0.4
x
|
EV / Revenue
|
4.2
x
|
2.73
x
|
4.02
x
|
0.81
x
|
0.53
x
|
0.51
x
|
EV / EBITDA
|
-5.16
x
|
-1.71
x
|
-3.07
x
|
-7.35
x
|
-1.73
x
|
-5.11
x
|
EV / FCF
|
-7.12
x
|
45.7
x
|
4.8
x
|
-25.2
x
|
-145
x
|
-19.6
x
|
FCF Yield
|
-14%
|
2.19%
|
20.8%
|
-3.97%
|
-0.69%
|
-5.09%
|
Price to Book
|
2.27
x
|
1.28
x
|
1.9
x
|
1.55
x
|
0.53
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
5,19,216
|
5,57,554
|
5,93,194
|
6,19,329
|
6,78,529
|
7,52,689
|
Reference price
2 |
1.250
|
0.4250
|
0.3950
|
0.3400
|
0.0920
|
0.1280
|
Announcement Date
|
16/07/18
|
23/07/19
|
17/07/20
|
27/07/21
|
18/07/22
|
27/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
153
|
89.37
|
54.79
|
276
|
152.6
|
238.8
|
EBITDA
1 |
-124.3
|
-143
|
-71.7
|
-30.44
|
-46.55
|
-23.67
|
EBIT
1 |
-129.4
|
-150.1
|
-78.21
|
-34.06
|
-48.06
|
-24.76
|
Operating Margin
|
-84.57%
|
-167.92%
|
-142.74%
|
-12.34%
|
-31.49%
|
-10.37%
|
Earnings before Tax (EBT)
1 |
-144.5
|
-161.2
|
-95.94
|
-28.93
|
-44.92
|
-25.2
|
Net income
1 |
-126.7
|
-138.6
|
-76.93
|
-26.4
|
-40.84
|
-21.67
|
Net margin
|
-82.76%
|
-155.09%
|
-140.42%
|
-9.56%
|
-26.76%
|
-9.07%
|
EPS
2 |
-0.2500
|
-0.3267
|
-0.1322
|
-0.0450
|
-0.0637
|
-0.0297
|
Free Cash Flow
1 |
-90.17
|
5.342
|
45.88
|
-8.877
|
-0.554
|
-6.163
|
FCF margin
|
-58.92%
|
5.98%
|
83.74%
|
-3.22%
|
-0.36%
|
-2.58%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/07/18
|
23/07/19
|
17/07/20
|
27/07/21
|
18/07/22
|
27/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
7.32
|
-
|
13.1
|
18.2
|
24.7
|
Net Cash position
1 |
6.84
|
-
|
14.2
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.0512
x
|
-
|
-0.4306
x
|
-0.39
x
|
-1.044
x
|
Free Cash Flow
1 |
-90.2
|
5.34
|
45.9
|
-8.88
|
-0.55
|
-6.16
|
ROE (net income / shareholders' equity)
|
-48.6%
|
-82.7%
|
-99.2%
|
-46.5%
|
-82%
|
-73.2%
|
ROA (Net income/ Total Assets)
|
-24.7%
|
-35.2%
|
-27%
|
-16.5%
|
-26.7%
|
-17.2%
|
Assets
1 |
513.5
|
393.6
|
285.1
|
160.2
|
152.9
|
125.7
|
Book Value Per Share
2 |
0.5500
|
0.3300
|
0.2100
|
0.2200
|
0.1700
|
0.1300
|
Cash Flow per Share
2 |
0.0200
|
0.0300
|
0.0300
|
0.0200
|
0.0200
|
0
|
Capex
1 |
20.1
|
0.89
|
0.06
|
0.11
|
-
|
0.04
|
Capex / Sales
|
13.16%
|
0.99%
|
0.11%
|
0.04%
|
-
|
0.02%
|
Announcement Date
|
16/07/18
|
23/07/19
|
17/07/20
|
27/07/21
|
18/07/22
|
27/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -42.82% | 35.15M | | -0.44% | 1.45B | | -3.32% | 1.43B | | -5.79% | 1.21B | | -14.59% | 899M | | +1.72% | 480M | | +3.85% | 440M | | -48.41% | 369M | | -19.75% | 356M | | -2.93% | 213M |
Medical Equipment Wholesale
|